Market Currents
Covidien (COV) plans to spin off its pharma business into a standalone public company. At...
-
Thursday, December 15, 2011, 7:38 AM ETCovidien (COV) plans to spin off its pharma business into a standalone public company. At present, the pharma unit accounts for $2B of sales. Post-split, Covidien's medical products business will generate around $9.6B in sales. (PR)
Other date
Latest Articles
